Inactive Instrument

Ambu A/S Share Price Nasdaq Copenhagen

Equities

DK0060591204

Medical Equipment, Supplies & Distribution

Financials

Sales 2024 * 5.28B 757M 60.58B Sales 2025 * 5.98B 857M 68.6B Capitalization 29.97B 4.29B 344B
Net income 2024 * 411M 58.87M 4.71B Net income 2025 * 615M 88.09M 7.05B EV / Sales 2024 * 5.71 x
Net Debt 2024 * 195M 27.93M 2.24B Net cash position 2025 * 159M 22.8M 1.83B EV / Sales 2025 * 4.98 x
P/E ratio 2024 *
73.1 x
P/E ratio 2025 *
48.9 x
Employees -
Yield 2024 *
0.33%
Yield 2025 *
0.46%
Free-Float 64.63%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 16/12/19
Director of Finance/CFO 40 12-31
Chief Tech/Sci/R&D Officer - 31/07/23
Members of the board TitleAgeSince
Chairman 56 08/12/20
Director/Board Member 64 31/12/11
Director/Board Member 54 31/12/14
More insiders
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
Calendar
More about the company